Norway's Omda Q1 revenue rises, helped by AI initiatives

Omda AS

21/05/2026 06:11

Overview

Norway niche healthcare software provider's Q1 2026 revenue grew, with continued profitability

Company reiterated 2026 guidance for revenue and EBITDA margin, supported by AI initiatives

M&A pipeline supports targeted 10-20% inorganic growth for 2026

Outlook

Omda reiterates 2026 revenue guidance of NOK 500-525 mln

Company expects 28-32% EBITDA margin for 2026, with further margin expansion from AI initiatives

Omda targets 10-20% inorganic growth in 2026, supported by progress in M&A pipeline

Result Drivers

AI INITIATIVES - Co said increased use of AI agents in software development, testing and documentation supported margin expansion

AI GOVERNANCE ROLLOUT - Co cited implementation of AI governance and operational AI tools as key value creation in Q1

M&A PIPELINE - Co said progress and maturity of M&A projects increased confidence in achieving guided inorganic growth

Company press release: ID:nObifrD2Ra

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
NOK 119 mln
NOK 129 mln (1 Analyst)

Analyst Coverage

The one available analyst rating on the shares is "strong buy"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Omda AS is NOK57.00, about 48.1% above its May 20 closing price of NOK38.50

The stock recently traded at 36 times the next 12-month earnings vs. a P/E of 49 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)